Some subpopulations of migrants to Europe are generally healthier than the population of
the country of settlement, but are at increased risk of key infectious diseases, including …

Objective This study aimed to investigate the prevalence of HIV late presentation and
advanced HIV disease and to identify the factors associated with HIV late presentation and …

Background The cross-sectional HIV care continuum is widely used to assess the success of
HIV care programmes among populations of people with HIV and the potential for ongoing …

Background As the life expectancy of people living with HIV increases with the
advancements in antiretroviral treatment, the continuity of long-term therapy and health care …

Abstract Objectives Late HIV diagnosis (CD4< 350 cells/mm3) is a key public health metric.
In an era of more frequent testing, the likelihood of HIV diagnosis occurring during …

Background HIV incidence in men who have sex with men (MSM) in the UK has remained
unchanged over the past decade despite increases in HIV testing and antiretroviral therapy …

Background: Nelonemdaz is a multitarget neuroprotectant that selectively blocks N-methyl-D-
aspartate receptors and scavenges free radicals, as proven in preclinical ischemia …

Early diagnosis is key to successful treatment of HIV. Before the advent of highly active
antiretroviral therapy (HAART) in 1996, HIV infection almost always resulted in a decline in …

Introduction The impact of TB disease on survival in people living with HIV in high resource
settings is not well documented in the antiretroviral treatment (ART) era. We calculated TB …

Background Migrants from certain regions are at increased risk of key infectious diseases
(including HIV, tuberculosis (TB), hepatitis B and hepatitis C). Although guidelines …